Comments
FDA approves Teva version of Amgen's Neupogen
30.08.2012. | WASHINGTON (Reuters) - U.S. drug regulators gave the nod to a Teva Pharmaceutical Industries drug that boosts the production of infection-fighting white blood cells in certain cancer patients receiving chemotherapy....
